TPPs: helping vaccines overcome post-approval obstacles

<strong>Vaccine
Volume 28, Issue 16, Pages 2799-2916 (1 April 2010)</strong>
http://www.sciencedirect.com/science/journal/0264410X

<strong><em>Short Communication</em></strong>
<strong>Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles</strong>
Pages 2806-2809
Bruce Y. Lee, Donald S. Burke

<em>Abstract</em>
As history has demonstrated, post-approval obstacles can impede a vaccine’s use and potentially lead to its withdrawal. Addressing these potential obstacles when changes in a vaccine’s technology can still be easily made may improve a vaccine’s chances of success. Augmented vaccine target product profiles (TPPs) can help vaccine scientists better understand and anticipate these obstacles and galvanize conversations among various vaccine stakeholders (e.g., scientists, marketers, business development managers, policy makers, public health officials, health care workers, third party payors, etc.) earlier in a vaccine’s development.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.